DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo

Masaki Ohyagi(Tokyo Medical and Dental University), Takanori Yokota(Tokyo Medical and Dental University)

Nature Communications

December 22, 2021

10.1038/s41467-021-26902-8

Cited by 22

Related Papers

Highly efficient silencing of microRNA by heteroduplex oligonucleotides

|Nucleic Acids Research|2019|40

Peripheral administration of nanomicelle-encapsulated anti-Aβ oligomer fragment antibody reduces various toxic Aβ species in the brain

|Journal of Nanobiotechnology|2023|23

Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model

|Nature Communications|2024|12

The Role of Long Noncoding RNA MALAT1 in Diabetic Polyneuropathy and the Impact of Its Silencing in the Dorsal Root Ganglion by a DNA/RNA Heteroduplex Oligonucleotide

|Diabetes|2022|7